Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway
Joo Kang Nam, Won Lee Ki, Evgeny A. Rogozin, Yong Yeon Cho, Yong Seok Heo, Ann M. Bode, Joo Lee Hyong, Zigang Dong
Dive into the research topics of 'Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway'. Together they form a unique fingerprint.